• Dividend Brief
  • Posts
  • Big Deals and Bigger Yields: Dividend Stories Shaping the Market This Week

Big Deals and Bigger Yields: Dividend Stories Shaping the Market This Week

From major acquisitions reshaping global markets to fresh dividend hikes, cuts, and upcoming payouts, there’s plenty for income-focused investors to digest this week.

Here are the dividend stories making headlines.

Never Miss a Stock Recommendation Again!

We now send our dividend picks right to your phone via text, so you’ll get the same actionable moves without having to open your inbox.

In partnership with

Learn from this investor’s $100m mistake

In 2010, a Grammy-winning artist passed on investing $200K in an emerging real estate disruptor. That stake could be worth $100+ million today.

One year later, another real estate disruptor, Zillow, went public. This time, everyday investors had regrets, missing pre-IPO gains.

Now, a new real estate innovator, Pacaso – founded by a former Zillow exec – is disrupting a $1.3T market. And unlike the others, you can invest in Pacaso as a private company.

Pacaso’s co-ownership model has generated $1B+ in luxury home sales and service fees, earned $110M+ in gross profits to date, and received backing from the same VCs behind Uber, Venmo, and eBay. They even reserved the Nasdaq ticker PCSO.

Paid advertisement for Pacaso’s Regulation A offering. Read the offering circular at invest.pacaso.com. Reserving a ticker symbol is not a guarantee that the company will go public. Listing on the NASDAQ is subject to approvals.

Healthcare

New Enhancements Signal Oracle’s Drive to Capture Long-Term Health IT Revenues

Oracle (NYSE: ORCL) has introduced enhancements to its Clinical One Data Collection system, including AI-enabled interoperability with electronic health records, expanded site-level data management, and integrated safety reporting.

The updates are designed to streamline clinical workflows, accelerate regulatory compliance, and support faster delivery of new therapies to market.

For equity holders, the relevance is not in the technology alone but in what it signals for Oracle’s business model.

By embedding itself deeper into the clinical trial ecosystem, Oracle secures long-duration, compliance-heavy contracts that mirror the sticky, recurring revenue streams investors prize in healthcare IT.

Pharmaceutical and biotech companies are unlikely to switch once systems are entrenched, giving Oracle durable positioning in a regulated industry where reliability carries a premium.

Prospective entrants should note that this move extends Oracle’s strategy of expanding its vertical-specific cloud and software offerings.

The life sciences segment presents an opportunity to diversify beyond traditional enterprise clients and reduce reliance on cyclical IT spending.

Competitors like Veeva and Medidata have carved strong niches, but Oracle’s scale, regulatory expertise, and ability to cross-sell into its cloud portfolio give it a differentiated edge.

For shareholders, the expansion underscores Oracle’s commitment to transforming healthcare IT into a significant revenue stream.

The integration of clinical and safety platforms strengthens its growth narrative and provides investors with added visibility on margin expansion potential.

ORCL currently trades at $236.00 and pays a dividend of $2.00 per share, a yield of 0.85%.

Retail

P&G Targets Imports With New Value-Priced Diaper Line at Target

Procter & Gamble (NYSE: PG) is introducing a new line of aloe-infused “bumbum” brand diapers, manufactured in China and sold exclusively at Target.

The launch comes as Pampers and Luvs face mounting pressure from lower-priced imports that are reshaping the $5.4 billion U.S. disposable diaper market.

For equity holders, the move underscores P&G’s willingness to diversify sourcing and adjust its portfolio to defend its share.

By producing bumbum overseas, the company can compete more directly with imported rivals such as Millie Moon, which already undercuts Pampers on price.

The strategy signals that P&G is prioritizing cost flexibility, even if it departs from its traditional U.S.-centric manufacturing model.

Market watchers should note the broader trend driving this decision.

Imports of diapers into the U.S. have more than tripled in weight over the past two years, while Pampers’ market share has slipped to 32.3%, and Luvs has lost ground to newer entrants.

Brands like Rascals and Millie Moon are expanding quickly by pairing premium features with lower price points, narrowing the gap in quality perception.

The bumbum launch highlights P&G’s balancing act between brand equity, competitive pricing, and margin protection.

For shareholders, it reflects a proactive stance in a category with declining birth rates, where innovation and cost management remain central to sustaining long-term value.

PG currently trades at $156.00 and pays a dividend of $4.23 per share, a yield of 2.70%.

Hidden Growth Signal (Sponsored)

You don’t need 100 trades to change your future. Sometimes, it only takes five.

Our team filtered through thousands of companies to identify the 5 best positioned for outsized returns.

These stocks were chosen for two reasons:

  1. Fundamentals strong enough to support sustained growth

  2. Technical momentum suggesting powerful upside potential

Past editions of this report uncovered stocks that soared +175%, +498%, even +673%.¹

Now it’s your turn to see the latest 5 hand-picked opportunities.

Why settle for average, when massive is within reach?

*This free resource is being sent by Zacks. We identify investment resources you may choose to use in making your own decisions. Use of this resource is subject to the Zacks Terms of Service.
*Past performance is no guarantee of future results. Investing involves risk. This material does not constitute investment, legal, accounting, or tax advice. Zacks Investment Research is not a licensed dealer, broker, or investment adviser.

Beverages

Coca-Cola Faces Strategic Pressure as Costa Coffee Falls Short

Coca-Cola (NYSE: KO) is reassessing its $5.1 billion acquisition of Costa Coffee after years of underperformance, underscoring the challenges of expanding into the highly competitive global coffee market.

Costa’s revenue has stagnated since 2018, slipping from £1.3 billion to £1.22 billion in fiscal 2023, a decline that highlights the brand’s struggle to generate growth momentum despite its broad international presence.

For investors, the Costa case reflects a misallocation of capital.

While Coca-Cola has secured a footprint of more than 4,000 stores and 14,000 vending machines worldwide, returns have fallen short of expectations, pressuring management to consider whether the asset aligns with the company’s broader beverage portfolio.

That underperformance contrasts with Coca-Cola’s core soft drink and sports drink categories, where margins and scale remain stronger.

Those evaluating Coca-Cola’s long-term positioning should focus on how coffee competes for resources with categories that have clearer profitability.

The Costa acquisition tied up billions at a time when the company faces headwinds from commodity volatility and shifting consumer preferences.

Coffee prices alone have surged to record highs in 2025, further pressuring margins.

KO currently trades at $68.00 and pays a dividend of $2.04 per share, a yield of 2.97%.

Dividend Stocks Worth Watching

Is Keurig Dr Pepper Inc. (NYSE: KDP) positioning itself to challenge Nescafé as the consumer coffee champion?

The beverage maker has just confirmed the $18 billion all-cash acquisition of Dutch coffee company, JDE Peet’s NV. JDE Peet includes the coffee brands Kenco, Douwe Egberts, and Peet's Coffee.

When the acquisition is complete, KDP will split into two separate entities: Beverage Co., focused on the North American soft drinks market, and Global Coffee Co., a global coffee group set to sell in more than 100 countries. 

KDP’s CEO Tim Cofer said the company’s operational strength and current momentum made this an opportune moment for the acquisition. 

KDP pays a 23-cent dividend with a yield of 3.16%. 

The department store chain, Kohl's Corporation (NYSE: KSS), is making solid progress in its turnaround plan after years of turmoil. KSS stock reached a nine-month high today (Wednesday, August 27) after revealing better-than-expected Q2 results.

An EPS of 56 cents was the standout result, beating Wall Street expectations by more than 20 cents.

Although revenue was down 5% year-over-year, Kohl's lifted its full-year guidance after a series of measures to lower costs and attract back customers started to take effect.

While a new partnership with Sephora is encouraging shoppers to return to stores before the holiday shopping season, the closure of 17 underperforming stalls, a cull of own-brand inventory, and a reduction in jewelry are proving successful as cost-cutting measures. 

KSS pays a dividend of $0.13 per share, yielding 3.18%. 

Dick's Sporting Goods' (NYSE: DKS) $2.4 billion acquisition of Foot Locker (NYSE: FL) has received shareholder approval from FL.

First announced back in May, the deal has just been greenlighted following a shareholder vote on Aug 22.

The acquisition is expected to close next month and will give Dick’s control of around 15% of the total sporting goods market in the USA. 

DKS pays $1.21 dividend with a solid 2.12% yield. Its dividend payment has increased each year for the last 11 years.

Dividend Increases

BNS has increased its dividend payment to $1.10, a rise of 37.57%. Its new yield is 7.68%. 

DGRW has increased its dividend payment to 8 cents, a rise of 30.77%. Its new yield is 1.17%. 

SAMG has increased its dividend payment to 21 cents, a rise of 5.00%. Its new yield is 5%.

Dividend Decreases

MSI has reduced its dividend payment to 1 cent per share, a 99% decrease. Its new yield is 0.01%. 

GSBD has reduced its dividend payment by 40% to 3 cents per share. Its new yield is 17.43%. 

MNSO has trimmed its dividend payment to 29 cents per share, a cut of 11.38%. Its new yield is 2.3%.

Growth Blueprint (Sponsored)

Q3 2025 is shaping up fast — and the right moves now could define the rest of your year.

That’s why we’ve just released a brand-new guide: The Top Seven Stocks for This Quarter.

Inside, you’ll discover:

Key sectors projected to surge this summer
Simplified insights for smarter decisions
 Data-driven expert picks designed for growth

This isn’t guesswork — it’s research-backed strategy for investors ready to position themselves ahead of the crowd.

Get your free copy now before the summer rally leaves you behind.

Poll: Which money lesson should they really teach in school?

Login or Subscribe to participate in polls.

Upcoming Dividend Payers

SBUX’s ex-dividend date for the forthcoming 61-cent payout is August 29, 2025.

ABR’s ex-dividend date for the forthcoming 30-cent payout is August 29, 2025.

CSWC’s ex-dividend date for the forthcoming 19-cent dividend is August 29, 2025.

Everything Else

  • Cracker Barrel's rebranding has been nothing short of disastrous, with fans hating the new logo and revamped interiors, but that could be good for business, experts say.

  • It’s a case of right place, right time for American Eagle this week. The clothing brand’s stock gained 5% after it launched its first Travis Kelce collection less than 24 hours after the NFL player announced his engagement to Taylor Swift.

  • Gas drilling company EQT has confirmed a 20-year definitive sales and purchase agreement with Sempra Infrastructure for the supply of 2 million tons of liquefied natural gas (LNG) per annum from the Port Arthur LNG Phase 2 development project in Jefferson County, Texas.

  • Just in time for back-to-school season, the frozen waffle brand Eggo® - part of the global snacking and frozen food company Kellanova – has expanded its lineup of protein waffles and pancakes.

That’s all for today’s edition of the Dividend Brief.

Thanks for reading, and if you have any feedback or dividend stocks you want me to take a look at, just reply to this email!

—Noah Zelvis
DividendBrief.com